Healthcare provider profile · identity verified

Juan E Mendez Servera, MD

General Practice · HORMIGUEROS, PR · NPI 1811128341

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	822	107
Atorvastatin Calcium	Atorvastatin Calcium	808	162
Gabapentin	Gabapentin	733	111
Losartan Potassium	Losartan Potassium	476	81
Alendronate Sodium	Alendronate Sodium	475	85
Metformin Hcl	Metformin Hcl	419	75
Famotidine	Famotidine	400	70
Lisinopril	Lisinopril	388	77
Metoprolol Succinate	Metoprolol Succinate	365	56
Simvastatin	Simvastatin	350	75
Tamsulosin Hcl	Tamsulosin Hcl	298	59
Omeprazole	Omeprazole	291	42
Duloxetine Hcl	Duloxetine Hcl	290	41
Pantoprazole Sodium	Pantoprazole Sodium	290	45
Glimepiride	Glimepiride	281	49
Clopidogrel	Clopidogrel Bisulfate	273	42
Finasteride	Finasteride	268	46
Pioglitazone Hcl	Pioglitazone Hcl	252	41
Amlodipine Besylate	Amlodipine Besylate	248	42
Rosuvastatin Calcium	Rosuvastatin Calcium	237	52
Hydrochlorothiazide	Hydrochlorothiazide	217	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	186	31
Montelukast Sodium	Montelukast Sodium	171	27
Albuterol Sulfate Hfa	Albuterol Sulfate	157	24
Clonazepam	Clonazepam	145	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	141	31
Metoprolol Tartrate	Metoprolol Tartrate	139	28
Donepezil Hcl	Donepezil Hcl	129	22
Tizanidine Hcl	Tizanidine Hcl	128	30
Alprazolam	Alprazolam	118	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	118	22
Synthroid	Levothyroxine Sodium	117	13
Etodolac	Etodolac	115	37
Glipizide	Glipizide	114	18
Furosemide	Furosemide	108	21
Memantine Hcl	Memantine Hcl	108	22
Citalopram Hbr	Citalopram Hydrobromide	106	15
Latanoprost	Latanoprost	105	15
Pravastatin Sodium	Pravastatin Sodium	101	16
Lantus	Insulin Glargine,hum.Rec.Anlog	85	12
Ezetimibe	Ezetimibe	83	13
Glipizide Er	Glipizide	82	suppressed
Nabumetone	Nabumetone	82	26
Amitriptyline Hcl	Amitriptyline Hcl	79	14
Carvedilol	Carvedilol	79	16
Trazodone Hcl	Trazodone Hcl	78	suppressed
Ibandronate Sodium	Ibandronate Sodium	76	15
Enalapril Maleate	Enalapril Maleate	75	13
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	72	suppressed
Sucralfate	Sucralfate	71	11
Cilostazol	Cilostazol	69	13
Spironolactone	Spironolactone	66	14
Galantamine Er	Galantamine Hbr	65	13
Atenolol	Atenolol	64	14
Farxiga	Dapagliflozin Propanediol	63	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	63	suppressed
Allopurinol	Allopurinol	62	suppressed
Meloxicam	Meloxicam	62	12
Fluoxetine Hcl	Fluoxetine Hcl	61	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	56	15
Diclofenac Potassium	Diclofenac Potassium	56	21
Fluticasone Propionate	Fluticasone Propionate	55	11
Sertraline Hcl	Sertraline Hcl	54	11
Irbesartan	Irbesartan	53	suppressed
Bumetanide	Bumetanide	52	suppressed
Metformin Hcl Er	Metformin Hcl	52	11
Ibuprofen	Ibuprofen	49	13
Tramadol Hcl	Tramadol Hcl	49	19
Metoclopramide Hcl	Metoclopramide Hcl	48	11
Temazepam	Temazepam	47	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	44	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	44	11
Chlorthalidone	Chlorthalidone	43	suppressed
Humulin N	Insulin Nph Human Isophane	42	suppressed
Nitroglycerin	Nitroglycerin	42	20
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Diclofenac Sodium	Diclofenac Sodium	40	20
Eliquis	Apixaban	38	suppressed
Meclizine Hcl	Meclizine Hcl	38	14
Nifedipine Er	Nifedipine	38	suppressed
Terazosin Hcl	Terazosin Hcl	37	suppressed
Timolol Maleate	Timolol Maleate	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	35	suppressed
Azithromycin	Azithromycin	35	34
Janumet Xr	Sitagliptin Phos/Metformin Hcl	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	13
Lumigan	Bimatoprost	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	30
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Risperidone	Risperidone	29	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Pentoxifylline	Pentoxifylline	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Piroxicam	Piroxicam	25	suppressed
Theophylline Er	Theophylline Anhydrous	25	suppressed
Levofloxacin	Levofloxacin	24	18
Levoxyl	Levothyroxine Sodium	24	suppressed
Prednisone	Prednisone	24	13
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Easy Touch	Syringe And Needle,insulin,1ml	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Levo-T	Levothyroxine Sodium	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Terbinafine Hcl	Terbinafine Hcl	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	12
Carbamazepine	Carbamazepine	20	suppressed
Digoxin	Digoxin	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Glyxambi	Empagliflozin/Linagliptin	19	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	19	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	19	15
Baclofen	Baclofen	18	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	18	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Lactulose	Lactulose	17	suppressed
Primidone	Primidone	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Naproxen	Naproxen	16	suppressed
Anastrozole	Anastrozole	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Ciclopirox	Ciclopirox	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	12	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cefadroxil	Cefadroxil	11	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Dexamethasone	Dexamethasone	11	11
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Orphenadrine Citrate Er	Orphenadrine Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error